143 related articles for article (PubMed ID: 20799046)
1. Elevated peritumoural rCBV values as a mean to differentiate metastases from high-grade gliomas.
Blasel S; Jurcoane A; Franz K; Morawe G; Pellikan S; Hattingen E
Acta Neurochir (Wien); 2010 Nov; 152(11):1893-9. PubMed ID: 20799046
[TBL] [Abstract][Full Text] [Related]
2. Solitary metastases and high-grade gliomas: radiological differentiation by morphometric analysis and perfusion-weighted MRI.
Hakyemez B; Erdogan C; Gokalp G; Dusak A; Parlak M
Clin Radiol; 2010 Jan; 65(1):15-20. PubMed ID: 20103416
[TBL] [Abstract][Full Text] [Related]
3. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging.
Hakyemez B; Erdogan C; Ercan I; Ergin N; Uysal S; Atahan S
Clin Radiol; 2005 Apr; 60(4):493-502. PubMed ID: 15767107
[TBL] [Abstract][Full Text] [Related]
4. High cerebral blood volume in human gliomas predicts deletion of chromosome 1p: Preliminary results of molecular studies in gliomas with elevated perfusion.
Law M; Brodsky JE; Babb J; Rosenblum M; Miller DC; Zagzag D; Gruber ML; Johnson G
J Magn Reson Imaging; 2007 Jun; 25(6):1113-9. PubMed ID: 17520715
[TBL] [Abstract][Full Text] [Related]
5. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas.
Sugahara T; Korogi Y; Kochi M; Ikushima I; Hirai T; Okuda T; Shigematsu Y; Liang L; Ge Y; Ushio Y; Takahashi M
AJR Am J Roentgenol; 1998 Dec; 171(6):1479-86. PubMed ID: 9843274
[TBL] [Abstract][Full Text] [Related]
6. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
7. Cerebral peritumoral oedema study: does a single dynamic MR sequence assessing perfusion and permeability can help to differentiate glioblastoma from metastasis?
Lehmann P; Saliou G; de Marco G; Monet P; Souraya SE; Bruniau A; Vallée JN; Ducreux D
Eur J Radiol; 2012 Mar; 81(3):522-7. PubMed ID: 21334839
[TBL] [Abstract][Full Text] [Related]
8. Correlation between dynamic susceptibility contrast perfusion MRI and methionine metabolism in brain gliomas: preliminary results.
Sadeghi N; Salmon I; Tang BN; Denolin V; Levivier M; Wikler D; Rorive S; Balériaux D; Metens T; Goldman S
J Magn Reson Imaging; 2006 Nov; 24(5):989-94. PubMed ID: 17031832
[TBL] [Abstract][Full Text] [Related]
9. [Value of relative cerebral blood volume measurement using perfusion MRI in glioma management].
Metellus P; Dutertre G; Mekkaoui C; Nanni I; Fuentes S; Ait-Ameur A; Chinot O; Dufour H; Figarella-Branger D; Cordoliani YS; Grisoli F
Neurochirurgie; 2008 Aug; 54(4):503-11. PubMed ID: 18573509
[TBL] [Abstract][Full Text] [Related]
10. A Magnetic Resonance comparative study between enhancement, rCBV and ACD in brain glioblastomas.
Aprile I; Muti M; Principi M; Bartolini N; Zenoni A; Tazza G; Italiani M; Ottaviano P
Radiol Med; 2002; 104(1-2):87-91. PubMed ID: 12386559
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging.
Hakyemez B; Erdogan C; Bolca N; Yildirim N; Gokalp G; Parlak M
J Magn Reson Imaging; 2006 Oct; 24(4):817-24. PubMed ID: 16958061
[TBL] [Abstract][Full Text] [Related]
12. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors.
Calli C; Kitis O; Yunten N; Yurtseven T; Islekel S; Akalin T
Eur J Radiol; 2006 Jun; 58(3):394-403. PubMed ID: 16527438
[TBL] [Abstract][Full Text] [Related]
13. Comparison of region-of-interest analysis with three different histogram analysis methods in the determination of perfusion metrics in patients with brain gliomas.
Young R; Babb J; Law M; Pollack E; Johnson G
J Magn Reson Imaging; 2007 Oct; 26(4):1053-63. PubMed ID: 17896374
[TBL] [Abstract][Full Text] [Related]
14. Dynamic susceptibility contrast-enhanced perfusion magnetic resonance (MR) imaging combined with contrast-enhanced MR imaging in the follow-up of immunogene-treated glioblastoma multiforme.
Stenberg L; Englund E; Wirestam R; Siesjö P; Salford LG; Larsson EM
Acta Radiol; 2006 Oct; 47(8):852-61. PubMed ID: 17050367
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of perfusion MRI in differentiating low-grade and high-grade gliomas: advanced MRI in glioma, A Siriraj project.
Direksunthorn T; Chawalparit O; Sangruchi T; Witthiwej T; Tritrakarn SO; Piyapittayanan S; Charnchaowanish P; Pornpunyawut P; Sathornsumetee S
J Med Assoc Thai; 2013 Sep; 96(9):1183-90. PubMed ID: 24163995
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of quantitative peritumoural perfusion and proton spectroscopic magnetic resonance imaging evaluation in differentiating brain gliomas from solitary brain metastases.
Sparacia G; Gadde JA; Iaia A; Sparacia B; Midiri M
Neuroradiol J; 2016 Jun; 29(3):160-7. PubMed ID: 26988081
[TBL] [Abstract][Full Text] [Related]
17. Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomas.
Catalaa I; Henry R; Dillon WP; Graves EE; McKnight TR; Lu Y; Vigneron DB; Nelson SJ
NMR Biomed; 2006 Jun; 19(4):463-75. PubMed ID: 16763973
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of methods for determining vascular permeability and blood volume in human gliomas.
Harrer JU; Parker GJ; Haroon HA; Buckley DL; Embelton K; Roberts C; Balériaux D; Jackson A
J Magn Reson Imaging; 2004 Nov; 20(5):748-57. PubMed ID: 15503330
[TBL] [Abstract][Full Text] [Related]
19. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH
Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234
[TBL] [Abstract][Full Text] [Related]
20. Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas.
Law M; Oh S; Johnson G; Babb JS; Zagzag D; Golfinos J; Kelly PJ
Neurosurgery; 2006 Jun; 58(6):1099-107; discussion 1099-107. PubMed ID: 16723889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
